Welcome to our dedicated page for Zimmer Biomet news (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet stock.
Zimmer Biomet Holdings, Inc. reports developments across its global medical technology business, including orthopedic reconstructive implants, surgical products, and integrated digital and robotic technologies that use data, analytics and artificial intelligence. Company updates commonly cover quarterly results and guidance, dividend actions, health care conference appearances, executive leadership changes, and clinical or operational data presented at orthopedic meetings.
Product-focused announcements describe musculoskeletal care technologies such as Oxford Cementless Partial Knee, Persona OsseoTi Keel Tibia, and HAMMR Automated Hip Impaction System, alongside broader portfolio themes in knees, hips, smart implants, robotics, AI and medical education.
Zimmer Biomet Holdings (NYSE: ZBH), a leader in musculoskeletal healthcare, will present at the Wells Fargo 2020 Virtual Healthcare Conference on September 9, 2020, at 11:20 a.m. ET. The presentation will feature President and CEO Bryan Hanson and Executive VP and CFO Suky Upadhyay. A live webcast of the event can be accessed via Zimmer Biomet's Investor Relations website and will be archived for future viewing. Founded in 1927, Zimmer Biomet is headquartered in Warsaw, Indiana, and operates globally in the orthopedic market.
Zimmer Biomet reported Q2 2020 net sales of $1.226 billion, a 38.3% decrease year-over-year. The company faced a net loss of $206.6 million, with adjusted net earnings of $10.2 million. The diluted loss per share was $1.00, with adjusted diluted EPS at $0.05, down 97.4% from the previous year. The ongoing impact of COVID-19 significantly affected elective procedures, with notable declines in sales across all regions and product categories. Despite recovery signs, uncertainty hampers future guidance.
Zimmer Biomet Holdings, Inc. (ZBH) will host its second quarter earnings conference call on August 4, 2020, at 8:30 a.m. ET. A news release detailing the quarterly results will be available at 6:30 a.m. ET on the same day. The call can be accessed via Zimmer Biomet's Investor Relations website, and a digital recording will be available from August 4 to October 4, 2020. For U.S. and Canada participants, the call can be joined by dialing (888) 312-9837 with conference ID 7278985.
Zimmer Biomet Holdings (NYSE: ZBH) introduces new features to its mymobility platform with Apple Watch, enhancing remote care management for joint replacement patients. The upgrade includes gait quality metrics, which provide real-time patient data and improve post-operative care management. These updates aim to optimize patient experience and reduce in-office visits. The new features will be showcased at the virtual WWDC 2020 from June 22 to 26, 2020, and will be available later this year. This digital transformation prioritizes effective patient management in the current healthcare landscape.